Mardi Dier, CFO of Madrigal Pharmaceuticals MDGL, has filed 3 purchases and 31 sales on the open market. Over the past 12 months that comes to a net sale of $3.8M. The latest trade was on 03/06.

MD

MD

Mardi Dier

EVP and CFO

Company

Madrigal Pharmaceuticals MDGL

First filing

23/05/04

Trades

52 trades

Buys / sales

3 / 31

12-month net buying

−$3.8M

Last trade

03/06

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Madrigal PharmaceuticalsMDGL	Open-market sale10b5-1 plan	03/06	03/06	1,982 sh12 trades	$430.87avg.	$853,992.6	−13.7%
Madrigal PharmaceuticalsMDGL	Open-market sale	03/02	03/02	1,183 sh	$427.21	$505,389.43	−11.3%
Madrigal PharmaceuticalsMDGL	Open-market sale10b5-1 plan	25/12/02	25/12/03	4,173 sh15 trades	$578.34avg.	$2,413,415.92	−28.6%
Madrigal PharmaceuticalsMDGL	Open-market sale10b5-1 plan	25/03/10	25/03/12	258 sh	$323.04	$83,344.32	−2.4%
Madrigal PharmaceuticalsMDGL	Open-market sale10b5-1 plan	25/03/03	25/03/05	1,961 sh2 trades	$324.96avg.	$637,251.39	−22.1%
AC Acelyrin	Open-market buy	23/05/09	23/05/11	7,306 sh3 trades	$18.00avg.	$131,508	No record